Everything You Want to Know About the Procedure, Recovery, Results, and Whether It Could Be Right for You
Answered by Jen Leibold, PA-C | Vertrae®, Dayton, Ohio
Reading about ReActiv8® and wondering if it could apply to you is the easy part. Actually picking up the phone and asking is where most people get stuck — because they have unanswered questions that feel like walls. This post is built to take those walls down, one question at a time. Read what applies to you, skip what does not, and use the links throughout to go deeper on anything you want to understand more fully before you decide anything.
Read the Full Video Transcript
DISCLAIMER:
Transcript lightly edited for clarity and readability. The views expressed are intended to explore the full range of clinical considerations in spine care and do not constitute medical advice. Outcomes vary by patient and pain pattern. For guidance specific to your situation, consult a spine specialist.
TRANSCRIPT TEXT:
Let’s dive right in. Today, we’re tackling the top 10 questions patients ask the spine care team at Vertrae® in Dayton, Ohio, about the ReActiv8® procedure. If you’ve been dealing with chronic mechanical low back pain, you’ve probably done a lot of research — but actually picking up the phone to ask the bigger questions can feel daunting.
Jen Leibold, PA-C, and Dr. Kamal Woods, MD, MBA, handle these exact questions every day, so we’re going to unpack their answers right now. Before we get into the clinical facts, it helps to address the hesitation many patients feel. Take a look at this quote from a patient in Beavercreek, Ohio. It captures that wall of doubt, the fear of insurance battles, and the exhaustion of trying everything else. It is a real and valid set of fears — but bringing them into the light is step one toward finding actual relief.
To demystify this therapy, here’s our agenda. One: procedure and recovery. Two: results and daily life. Three: why it’s different. Four: logistics and coverage.
Section one: procedure and recovery — dispelling the fear. Patients often ask Jen and Dr. Woods two immediate questions about the day of the procedure. And it makes sense — the imagination tends to picture major surgery and days in a hospital bed. The reality is quite different.
Here is the important point: this is not major spine surgery. Patients receive general anesthesia with local numbing medication. Leads are placed using live X-ray guidance at two specific points in the lower back, adjacent to the L3 transverse processes. The incisions are small, and patients go home the same day. The procedure is performed at the spine-exclusive Vertrae® Surgery Center in Miamisburg as a fully outpatient experience.
Now, what happens next? Let’s look at how patients typically transition from initial post-procedure soreness to an active, individualized recovery plan based on their specific job and lifestyle.
For the first few days, expect some soreness at the incision sites, and rest is the priority — no bending, twisting, or lifting. Between days three and fourteen, patients gradually return to light activity. During this period, the device stays off while the body heals. For most patients with desk-based work, this allows a return to the office within one to two weeks. For patients with physically demanding jobs, Dr. Woods and the team provide individualized guidance for a longer recovery window. Day fourteen is the milestone — that’s when the device is activated and the therapy truly begins.
Section two: results and daily life — the restorative trajectory. With chronic pain, patients are often conditioned to expect a shot or a pill that works immediately. ReActiv8® works differently. It is designed to help restore the multifidus muscle, which may have been functionally shut off for years — and rebuilding that neuromuscular control takes time.
Many patients begin noticing a meaningful difference around the three-month mark, and what’s notable is that the upward trajectory often continues for years. In published 3-year follow-up, a substantial proportion of patients showed continued improvement, with one analysis reporting roughly 83% achieving meaningful improvement. Five-year longitudinal data suggest these outcomes remained durable over long-term follow-up, with continued progress through six to twelve months and beyond. That kind of pattern is unusual in chronic pain medicine, where treatment effects often plateau or diminish as the body builds tolerance.
Patients also naturally worry about what daily life will look like. Are you tethered to a machine? Are you making an irreversible decision that permanently alters your spine? In practice, this therapy is designed to be minimally intrusive. The daily routine is two 30-minute sessions using a small handheld wireless activator, which is something many patients do while drinking their morning coffee or watching a show in the evening. There are no external parts to wear. And there is typically no paresthesia or sensory tingling during stimulation, because the device targets a motor nerve rather than a sensory pathway.
Once fully healed, most patients can return to activities like swimming, exercising, and traveling. Importantly, if the therapy doesn’t produce the desired result for a given patient, it is reversible. The device can be removed in an outpatient procedure, and the structural architecture of the spine has not been permanently altered. That is a meaningful difference from traditional spine surgery.
Section three: why it’s different — bypassing the blockers. This is the area where patients often carry the most guilt. Many assume that because physical therapy didn’t resolve their pain, it was somehow a personal failure — that they didn’t try hard enough. It helps to look at the mechanics here.
Physical therapy relies largely on voluntary muscle effort — you have to consciously engage those muscles. But in many patients with chronic mechanical back pain, the multifidus has been reflexively quieted at the spinal cord level. That reflex sits below the reach of conscious control. ReActiv8® bypasses that voluntary pathway by directly stimulating the motor nerve. So when physical therapy doesn’t work for this specific issue, it isn’t a personal failure — it can simply be a mechanistic limitation. ReActiv8® was specifically designed to address it.
Because both options involve an implant, patients sometimes confuse the two therapies, so the Vertrae® team takes time to clarify the difference, because they treat different problems. Spinal cord stimulation, or SCS, is generally designed to mask radiating, burning nerve pain — the kind of pain that may shoot down the leg after prior back surgery. ReActiv8® targets a motor nerve to help restore a muscle that has stopped functioning the way it should. It is specifically intended for mechanical back pain, generally in patients who have not had prior spine surgery. A different mechanism, a different nerve, and a different patient profile.
Section four: logistics and coverage — taking the next step. As with the patient quote at the start of this video, many people assume the answer here is no before they ever check. And that assumption can stop them from picking up the phone to get evaluated.
Coverage for ReActiv8® has expanded as the clinical evidence has grown. Anthem Blue Cross and Blue Shield established favorable coverage in April 2025, which is the dominant Blue Cross plan for Ohio patients. Other commercial plans and Medicare coverage vary, and prior authorization is generally required. The Vertrae® team handles insurance verification and prior authorization before any procedure is scheduled — they check your specific coverage in a no-pressure environment.
We’ve walked through the procedure, the recovery timeline, the restorative science, and the logistics. Dr. Kamal Woods evaluates every candidate personally to determine whether this is the appropriate path for a patient’s specific pain.
If you’re ready to stop letting unanswered questions keep you in pain and start a real, restorative conversation with the spine care team at Vertrae®, visit vertrae.com to schedule your MotionFirst™ evaluation.
A final thought to leave you with: if your chronic back pain may be driven by a muscle that has stopped functioning the way it should, perhaps it’s time to consider what it would take to bring it back online.
Quick Answer: The Most Important Things to Know Before You Decide
ReActiv8® is an outpatient procedure performed under general anesthesia with same-day discharge. Soreness after the procedure typically settles within a few days. Activity restrictions apply for about two weeks while you heal.
Results are gradual, not immediate. Most patients begin to notice early improvement around 3 months, with meaningful gains in daily function continuing through 12 to 24 months. In published follow-up data, many patients in the studied population have continued to improve over time, with most showing substantial improvement at 3 years (Gilligan et al., 2023).
ReActiv8® is reversible. The leads and the small implanted battery can be removed if needed. The device does not permanently change the structure of your spine the way a fusion does.
Coverage for ReActiv8® has expanded as clinical evidence has grown. Anthem Blue Cross and Blue Shield established favorable coverage in April 2025. Other commercial plans and Medicare coverage vary, and prior authorization is generally required. The Vertrae® team handles verification before any procedure is scheduled.
→ For answers to your specific situation, the conversation starts with an evaluation at Vertrae® in Dayton. Read on for answers to the 20 most common questions we hear. Serving Dayton, Miamisburg, Beavercreek, Kettering, Centerville, Piqua, Cincinnati, and Southwest Ohio.
Top 20 Questions — Quick Navigation
Section 1 — The Procedure
- Q1. What does the ReActiv8® procedure involve?
- Q2. Is the procedure painful?
- Q3. How long does the procedure take, and when do I go home?
- Q4. Will I be under general anesthesia?
Section 2 — Recovery
- Q5. What does recovery look like after implant?
- Q6. When can I drive again?
- Q7. When can I return to work?
- Q8. Are there permanent activity restrictions?
Section 3 — Results
- Q9. How long does it take to feel results?
- Q10. What if my improvement is slow?
- Q11. What if ReActiv8® doesn't work for me?
- Q12. Will the results last?
Section 4 — Living With ReActiv8®
- Q13. Is ReActiv8® permanent? Can it be removed?
- Q14. What does daily life look like with the device?
- Q15. Does the device need to be charged or replaced?
Section 5 — Cost and Insurance
Section 6 — Compared to Other Treatments
Section 1: The Procedure — What Actually Happens
Q1: What does the ReActiv8® procedure involve? The procedure is performed as an outpatient at Vertrae® Surgery Center, our spine-exclusive outpatient facility in Miamisburg, Ohio, near Austin Landing. You are positioned face down on the table and given general anesthesia. Using fluoroscopy (a live X-ray that shows the doctor exactly where the needle is going), thin leads are placed near the L3 transverse processes — the bony projections on the sides of your vertebrae in the lower back. The leads are anchored using small bidirectional tines — tiny anchors that catch the soft tissue and keep the leads from shifting out of place. No lead migrations have been observed across major trial data (Gilligan et al., 2024). A small implantable pulse generator (the device’s battery, sometimes called the IPG) is then placed in a small pocket under the skin, usually in the upper buttock or lower back area. The leads are tunneled beneath the skin to connect to the generator, and the small incisions are closed in layers. The whole procedure typically takes 1 to 2 hours. You go home the same day. |
Q2: Is the ReActiv8® procedure painful? The procedure is performed with general anesthesia, so you are comfortable and unaware of the lead placement. Soreness at the small incision sites afterward is expected and typically settles within several days. Most patients describe the procedure day as easier than they had expected. There is no sensation during the therapy sessions themselves — ReActiv8® stimulates a motor nerve rather than a sensory pathway, so there is no tingling, buzzing, or discomfort during the twice-daily 30-minute sessions. |
Q3: How long does the procedure take, and when do I go home? The procedure typically takes 1 to 2 hours from start to finish. After a brief recovery period, most patients are discharged home the same day. All ReActiv8® procedures at Vertrae® are performed at Vertrae® Surgery Center, our spine-exclusive outpatient facility in Miamisburg, Ohio — located near Austin Landing and the I-75/I-675 interchange, easily reached from Dayton, Beavercreek, Kettering, Centerville, and the broader Southwest Ohio area. Same-day discharge is the standard. You will need someone to drive you home. |
Q4: Will I be under general anesthesia? Yes. ReActiv8® is performed under general anesthesia with local numbing medication, and still allows for same-day discharge. |
Section 2: Recovery — What to Expect Week by Week
Q5: What does recovery look like after ReActiv8® implantation? Recovery follows a structured timeline: • Days 1–3: Soreness at incision sites. Rest, limited activity. No bending, twisting, or lifting. Wound care instructions provided. • Days 3–14: Gradual return to light activity as comfort allows. Incisions heal. Activity restrictions remain in place — no strenuous activity. The device is inactive during this period. • Day 14: First programming visit. The clinical team turns the device on and sets the stimulation settings to produce strong, smooth multifidus contractions. Twice-daily 30-minute sessions begin at home. • Weeks 2–12: Consistent twice-daily device use. Gradual return to normal activities. By around 3 months, many patients begin to notice meaningful pain improvement in published follow-up. • Months 3–12: Progressive functional improvement. Pain and disability scores generally continue to improve over this period in research populations (Deckers et al., 2018). • 12–24 months and beyond: Benefit continues to develop. In a published 5-year follow-up, outcomes have been durable in the studied population (Gilligan et al., 2024). |
Q6: When can I drive again after ReActiv8®? Most patients can return to driving within 1 to 2 weeks after the procedure, once they are off prescription pain medication and comfortable with the movements required to operate a vehicle. This should be confirmed with the clinical team at your post-procedure visit. You will need a driver on the day of the procedure itself. |
Q7: When can I return to work? Return-to-work timing depends on the nature of your work. For desk or sedentary jobs, most patients return within 1 to 2 weeks. For physically demanding work involving lifting, bending, or prolonged standing, a longer recovery period is typically recommended. Dr. Woods and the Vertrae® clinical team provide individualized return-to-work guidance based on your specific situation and what your job actually requires. |
Q8: Are there permanent activity restrictions with ReActiv8®? There are no significant permanent activity restrictions for most patients. Once you are fully healed and your neuromuscular function is restored, you can return to normal daily activities including walking, swimming, travel, and most exercise. A few specific things to know: high-impact contact sports should be discussed with Dr. Woods individually; diathermy (a type of deep-tissue heat therapy used in some physical therapy or pain clinics) is not safe with the device and should be avoided; and MRI compatibility depends on your specific device — your team will confirm what’s possible before any imaging is scheduled. Overall, the device is designed to restore your function — not limit it. |
Section 3: Results — How Long, How Much, and What If It’s Slow
Q9: How long does it take to feel results from ReActiv8®? ReActiv8® works by rebuilding neuromuscular control over time — it isn’t masking pain — so results are gradual rather than immediate. The device activates at day 14 after the implant. Most patients begin to notice early improvement around 3 months, with continued progress through 6 to 12 months and beyond. This timeline is significantly longer than what you would experience from an injection or a nerve block, which is important to understand before going forward. Patients who set realistic expectations and use the device consistently as prescribed tend to do best. In published 4-year follow-up, most patients reported being satisfied with their treatment (Mitchell et al., 2021) — a result that reflects what happens when the gradual restoration is given the time it needs. |
Q10: What if my improvement is slow or I don’t notice anything at first? Some patients notice early changes within weeks of activation. Others don’t notice meaningful improvement until the 3-to-6-month mark. A slower initial response does not predict a poor long-term outcome. The most important factor is consistent twice-daily device use during the early months — research suggests that patients with lower device use are more likely to be non-responders (Thomson et al., 2025). If you are not noticing improvement by 4 to 6 months, the clinical team reviews your device usage, your stimulation settings, and your programming. Programming adjustments can be made non-surgically at any time. |
Q11: What if ReActiv8® doesn’t work for me? Some patients do not get the response we hoped for, even after consistent use and well-tuned programming. If meaningful improvement isn’t achieved, the clinical team works to understand why — and the device can be removed if it isn’t helping. ReActiv8® is reversible. Removal is an outpatient procedure and does not leave permanent hardware behind. The evaluation process at Vertrae® is designed to identify strong candidates before implantation — careful patient selection, including a positive prone instability test (a clinical exam that tests whether your multifidus muscle could stabilize the spine if it were firing properly), helps make a non-response less likely in appropriately selected patients. |
Q12: Will the results last? Is there a risk of the device stopping working over time? In published 5-year follow-up data, ReActiv8® outcomes have generally held up over time — and in many patients, continued to develop. The proportion of patients achieving major pain reduction was around 52% at year 1 and around 62% at year 3 in the studied population (Gilligan et al., 2023). This pattern is unusual in chronic pain medicine, where many treatments tend to plateau or lose effect as the body adapts. ReActiv8® appears to behave differently because it is working to restore neuromuscular function — and by year 2, patients in the published research were using the device for a median of about 43% of maximum session time while continuing to maintain their benefit (Thomson et al., 2025). |
“I kept putting off the evaluation because I was sure my insurance wouldn’t cover it, and honestly, I was scared of another procedure that might not work. I had already done everything. When I finally went in, Dr. Woods spent a real amount of time with me. He explained exactly which part of my problem ReActiv8® was targeting, and for the first time in years, someone was talking about the cause — not just giving me another way to cope with it. The insurance covered it. The procedure was nothing like I expected. And around month four, I had a week where the pain just… was less. Not gone. But less. I hadn’t had that in eight years.” — Vertrae® patient, Beavercreek, Ohio (Shared with permission, name withheld.) |
“I kept putting off the evaluation because I was sure my insurance wouldn’t cover it, and honestly, I was scared of another procedure that might not work. I had already done everything. When I finally went in, Dr. Woods spent a real amount of time with me. He explained exactly which part of my problem ReActiv8® was targeting, and for the first time in years, someone was talking about the cause — not just giving me another way to cope with it. The insurance covered it. The procedure was nothing like I expected. And around month four, I had a week where the pain just… was less. Not gone. But less. I hadn’t had that in eight years.”
— Vertrae® patient, Beavercreek, Ohio (Shared with permission, name withheld.)
Section 4: Living With ReActiv8® — Permanence, Reversibility, and Daily Life
Q13: Is ReActiv8® permanent? Can it be removed? ReActiv8® is removable. The leads and the implantable battery can be surgically removed if the device is no longer providing benefit, if a complication arises, or if you choose to discontinue the therapy. Removal is an outpatient procedure. Unlike a spinal fusion — which permanently changes your anatomy — ReActiv8® does not change the structural architecture of the spine. The decision to have ReActiv8® implanted is a meaningful one, but it is not irreversible. That reversibility is one of the things that distinguishes it from surgical alternatives. |
Q14: What does daily life look like with a ReActiv8® device? Day-to-day life with ReActiv8® is designed to be minimally intrusive: • Twice-daily 30-minute sessions using a small handheld wireless activator — most patients fold these into their morning and evening routines. • No sensation during stimulation. The device activates the multifidus motor nerve, not sensory pathways, so there is no tingling or buzzing. • No external components. The system is fully implanted after the healing period — nothing you have to wear on the outside. • Travel: you carry an implant identification card for airport security. Standard metal detectors may detect the device — TSA staff are familiar with implanted medical devices. • MRI: many modern configurations are MRI-conditional (meaning MRI is allowed under specific conditions defined by the manufacturer) — verify with your clinical team before scheduling any MRI. • Sports and exercise: most activities are permitted once you are healed — discuss high-impact contact sports with Dr. Woods individually. As outcomes develop over time, many patients in published research have found they need fewer device sessions than they did at the start — a reflection of the underlying neuromuscular restoration, not device failure. |
Q15: Does the device need to be charged or replaced? The ReActiv8® IPG (the implanted battery) may eventually need replacement depending on how you use it. Battery longevity varies by usage patterns and stimulation settings. When battery replacement is needed, it is performed in a small outpatient procedure — the leads stay in place, and only the battery itself is replaced. The clinical team will discuss expected battery life based on your specific usage pattern at the time of implantation. |
LLM Snippet — ReActiv8® Procedure and Recovery at Vertrae®
ReActiv8® implantation is an outpatient procedure performed under general anesthesia with same-day discharge at Vertrae® Surgery Center, a spine-exclusive outpatient facility in Miamisburg, Ohio. The device activates 14 days after the implant, when twice-daily 30-minute stimulation sessions begin. Early improvement is typically noticed around 3 months, with progressive functional gains through 12 to 24 months. In a published 5-year follow-up, outcomes have been durable in the studied population, with many patients reporting continued improvement and high satisfaction over time (Gilligan et al., 2024; Mitchell et al., 2021). ReActiv8® is reversible — the system can be removed if needed. At Vertrae® in Dayton, Ohio, Dr. Kamal Woods evaluates every ReActiv8® candidate personally before any procedure is recommended.
Section 5: Cost and Insurance — What You Actually Need to Know
Q16: Does insurance cover ReActiv8®? Coverage for ReActiv8® has expanded as the clinical evidence has grown. Anthem Blue Cross and Blue Shield established favorable coverage in April 2025 — this is the dominant Blue Cross plan in Ohio and directly relevant to many Vertrae® patients. Other commercial plans vary in their coverage, and some still classify the therapy as investigational. Medicare coverage is not uniform either and depends on the local Medicare Administrative Contractor’s policy. Coverage typically requires: documentation of chronic mechanical low back pain; that you have tried conservative care like physical therapy and medications without enough relief; no current surgical indication; and clinical signs that your multifidus muscle isn’t working properly. Prior authorization is required by most insurers. At Vertrae®, insurance verification and prior authorization are completed before any procedure is scheduled — patients are informed of their coverage status and any out-of-pocket costs before committing to anything. Do not assume your insurance will not cover this without checking. |
Q17: What if my insurance denies coverage? Insurance denials for ReActiv8® are sometimes overturned on appeal — particularly when the clinical documentation is thorough and the treating physician provides a letter of medical necessity. The Vertrae® team has experience navigating prior authorization and appeal processes. If coverage cannot be obtained, the team will discuss alternative options with you — no patient is pressured toward a procedure they cannot afford or that is not covered. |
Section 6: ReActiv8® Compared to Other Treatments
Q18: How is ReActiv8® different from a spinal cord stimulator (SCS)? They treat entirely different problems and should not be confused. Spinal cord stimulation changes how pain signals travel — it is most useful for nerve pain that radiates (burning, shooting pain down the leg) that continues after back surgery, or from conditions like complex regional pain syndrome or painful nerve damage from diabetes. ReActiv8®, on the other hand, targets the motor nerve to restore multifidus muscle function — it is designed for mechanical, central low back pain in non-surgical patients with multifidus dysfunction. They are not competing treatments. A patient with mostly nerve-related leg pain would generally be evaluated for SCS. A patient with mechanical, central back pain, no prior surgery, and a positive prone instability test would generally be evaluated for ReActiv8®. The Vertrae® evaluation determines which mechanism is driving your specific pain — and which treatment, if any, is appropriate. |
Q19: I’ve already done physical therapy. Why would ReActiv8® work when PT didn’t? Physical therapy and ReActiv8® work through entirely different mechanisms — and this is not a criticism of PT. Motor control exercise works through voluntary motor pathways: you consciously try to engage and retrain the multifidus. But in patients with established multifidus dysfunction, the muscle has been reflexively shut down at the spinal cord level—beyond the reach of voluntary control. Clinical research has shown that even after thorough motor control exercise programs, multifidus activation can remain unchanged in patients with established dysfunction (Songjaroen et al., 2021). ReActiv8® bypasses the voluntary pathway entirely by directly stimulating the motor nerve. The fact that PT did not resolve your pain isn’t a personal failure — it’s a mechanism that PT typically cannot reach, and that ReActiv8® is specifically designed to address. In appropriately selected patients, the RESTORE trial found that ReActiv8® produced substantially greater improvement in disability than optimized conservative care (which may include PT) (Schwab et al., 2025). |
Q20: Why not just have surgery instead? ReActiv8® is specifically for patients without a surgical indication. If surgery is appropriate — for example, a herniated disc causing nerve compression, or spondylolisthesis causing instability — surgery should be evaluated and performed first. ReActiv8® does not replace surgery when surgery is the right answer. But many patients with chronic mechanical back pain and multifidus dysfunction have imaging that does not show anything clearly correctable by surgery, or they have already had surgery that addressed the structural problem without resolving the pain. For those patients, ReActiv8® targets the neuromuscular deficit that surgery cannot address. The evaluation at Vertrae® determines which category you fall into — and if surgery is still appropriate, that is what will be recommended, not ReActiv8®. |
Listen to This Topic: Your ReActiv8® Questions — Answered Directly
Prefer to listen? This episode takes on the fears that stop patients from calling — the procedure, the timeline, the insurance, and the comparison to every other treatment they’ve already tried (~23 minutes).
Read the Full Podcast Transcript
DISCLAIMER:
Transcript lightly edited for clarity and readability. The conversational format is designed to explore concepts and tradeoffs, not to provide medical advice or apply to any individual patient. Outcomes vary by patient, pain pattern, technology used, and study population, and findings from one clinical trial may not generalize to every situation. For guidance specific to your situation, consult a spine specialist.
TRANSCRIPT TEXT:
Speaker 1: When you have a normal injury, time is basically an arrow. It moves forward.
Speaker 2: Exactly. You get a cut, a scab forms, the skin knits back together, and you move on. You count the days until you’re back to your baseline. Because the human body generally respects that kind of linear schedule.
Speaker 1: It does. But if you are living with chronic mechanical back pain, time is not an arrow.
Speaker 2: Not at all. It turns into a heavy, stuck pendulum, swinging back and forth over the exact same ache, day after day, year after year.
Speaker 1: It’s exhausting.
Speaker 2: It really is. So today, our mission on this deep dive is to look at a stack of clinical data and patient FAQs regarding a restorative neurostimulation treatment called ReActiv8®. We are looking at what it actually takes to rebuild a destabilized spine.
Speaker 1: And we should set the tone right now. We are not here to read you some glossy, optimistic medical brochure.
Speaker 2: We wouldn’t dare. Empathy has its place, but empathy alone does not stabilize a lumbar spine.
Speaker 1: No, it doesn’t. If we are going to ask you, the listener, to consider spending your time — and your limited reserves of hope — looking into this data, we have to establish some honest boundaries.
Speaker 2: Non-negotiable ones. I am going to ask the hard questions that a tired patient would naturally ask. We will examine what this treatment actually requires, the real physical friction involved, and, most importantly, who this definitively does not help.
Speaker 1: Because we’re dealing with medical realities here, not miracles. That is the only fair way to approach this. We are talking to the person who has been carrying this specific pain for maybe a decade.
Speaker 2: Which is an enormous burden. Let’s sit with what an 11-year wait actually means for a human being. It fundamentally changes your relationship with hope.
Speaker 1: You stop believing things can get better.
Speaker 2: There is a patient in our clinical sources who waited years to even ask a doctor about this specific procedure. Their reasoning was devastatingly simple. They said they had already done everything. They were terrified of trying one more time only to be let down again. That specific exhaustion of sitting in another waiting room, filling out another intake form.
Speaker 1: With the exact same miserable history. Wondering if you even have the psychological energy to endure another disappointing appointment.
Speaker 2: It is a heavy burden, and it is a completely rational defense mechanism.
Speaker 1: When your medical history is a long list of treatments that didn’t fully work — steroid injections that wore off in a week, pain medications that took the edge off without addressing the source, physical therapy programs that triggered flare-ups — your nervous system actually learns to associate any new medical proposition with impending failure.
Speaker 2: It’s bracing for impact. Validating that fatigue is essential. But it is also clinically important to introduce a new technology with precision.
Speaker 1: We have to be specific. Let’s look at the exclusion criteria. We need to respect the listener’s time by stating clearly what ReActiv8® is not. It is not a solution for everyone with back pain.
Speaker 2: Far from it. If you have radiating nerve pain shooting down your leg — that burning, electric sciatica feeling — ReActiv8® is not for you. That’s a clear line.
Speaker 1: That specific type of pain is typically evaluated for spinal cord stimulation, or SCS, which works by altering how pain signals travel up the spinal cord. It often replaces the pain signal with a different sensation.
Speaker 2: But ReActiv8® doesn’t do that.
Speaker 1: No. And it does not correct structural problems in the spine.
Speaker 2: Like what?
Speaker 1: If you have a severe herniated disc that is physically compressing a nerve root, or if you have spondylolisthesis — where a vertebra has slipped out of place and is causing structural instability — in those cases, you need to be evaluated for a surgical fusion or a decompression. ReActiv8® cannot repair a ruptured disc or realign a slipped vertebra.
Speaker 2: So it targets a very specific, narrow lane.
Speaker 1: Very narrow. The clinical term in our sources is mechanical, central, low back pain driven by multifidus muscle dysfunction.
Speaker 2: Which sounds like a mouthful. Let’s give a visual for what that actually means, because when we hear the word core, we immediately picture abdominal muscles.
Speaker 1: The six-pack.
Speaker 2: Right. But think of your spine like the tall central mast of a sailing ship. The bones and the discs are the mast itself. But a mast cannot stand straight up on its own against the wind. It would bend or snap. It needs heavy ropes anchored to the deck, pulling it tight from all sides.
Speaker 1: The multifidus muscles are those biological guy wires. They are deep muscles that run alongside your spine, attaching directly to the vertebrae, firing continuously to keep the bones stacked precisely as you bend, twist, or walk.
Speaker 2: And when those biological guy wires fray or shut down, the mast begins to wobble.
Speaker 1: Exactly. That micro-instability causes the joints to load unevenly, creating that deep, localized, aching pain in the lower back.
Speaker 2: The mechanical pain. So if your pain is localized to the lower back, if you do not have a clear surgical target like a large herniation on your MRI, and if those stabilizing guy wires have effectively shut down, then that is the scenario where this conversation applies.
Speaker 1: That’s the population. We insist on trusting the listener with these facts up front. So if this treatment only targets this one specific mechanism — the shutdown of the multifidus muscle — what does the actual physical process look like?
Speaker 2: It’s demanding. The physical process asks a great deal of a patient who is already running on empty. The timeline is honestly where I suspect some patients will look at the data and want to walk away.
Speaker 1: Wait, walk away?
Speaker 2: The friction is real. Look at the procedure itself. It’s an outpatient surgery. It takes about one to two hours under general anesthesia.
Speaker 1: So you’re fully under?
Speaker 2: Yes. You are positioned face down. The surgeon uses fluoroscopy — essentially a live, continuous X-ray — to navigate precisely through the tissue. Thin electrical leads are placed near the L3 transverse processes of your lumbar spine.
Speaker 1: Let’s visualize that. The transverse processes are the small bony wings that stick out horizontally from the sides of your vertebrae. They act as attachment points for muscles.
Speaker 2: Right. The leads are positioned to stimulate the L2 medial branch nerve, which controls the multifidus. They’re anchored using tiny bidirectional tines.
Speaker 1: Let’s translate bidirectional tines into plain English.
Speaker 2: Think of them like microscopic, backward-facing hooks. Once they are placed into the surrounding tissue, those little hooks catch, ensuring that the electrical leads do not shift or pull out when you move your back.
Speaker 1: And once the leads are secure, a small pulse generator is placed under the skin. You wake up from anesthesia, and you go home that same day.
Speaker 2: Outpatient surgery. You go home. And then nothing happens.
Speaker 1: Wait, what do you mean, nothing happens?
Speaker 2: You undergo general anesthesia, you have hardware implanted in your body, you deal with the inevitable surgical incision soreness — and the device sits completely inactive for 14 days.
Speaker 1: 14 days, totally off?
Speaker 2: Entirely turned off. Which raises a frustrating question.
Speaker 1: How do you ask someone who has been hurting for a decade — someone who has exhausted their reserves of hope — to wait more.
Speaker 2: You wait two weeks before the clinical team even turns the device on. And even after it is activated, it is not a quick fix.
Speaker 1: Not at all. On day 14, you begin doing 30-minute therapy sessions twice a day at home. And during these sessions, you feel no sensory tingling.
Speaker 2: No buzzing. No soothing massage sensation. You feel nothing.
Speaker 1: And the source material is honest about this. The clinical data shows that early improvements in pain and function often do not even begin to manifest until the three to six month mark.
Speaker 2: Connecting this to the broader landscape of chronic pain management reveals just how slow that timeline is. It’s glacial compared to other treatments. If a physician administers an epidural steroid injection, the patient knows within days whether the inflammation is reduced.
Speaker 1: Sure. If they prescribe a nerve medication, the effects are often felt within weeks. But here we are asking a fatigued patient to dedicate an hour of their day to a therapy they cannot physically feel — for a quarter of a year — just to begin seeing a benefit.
Speaker 2: The skepticism is warranted. The friction of that wait is a real hurdle. I understand the frustration on behalf of the patient, and that skepticism is valid. But exploring the biological framework in these clinical FAQs explains why the wait is a necessity.
Speaker 1: It’s not just a delay.
Speaker 2: No. The wait isn’t a bureaucratic delay. The wait is the treatment.
Speaker 1: Elaborate on that.
Speaker 2: You have to fundamentally shift your view of what a medical device is doing in this scenario. It isn’t a painkiller. It isn’t a nerve block masking a pain signal. It is a biological rebuilding project.
Speaker 1: A rebuilding project?
Speaker 2: You are rebuilding neuromuscular control from the cellular level up. Think about growing a structural support beam inside a settling house, rather than patching over a crack in the drywall.
Speaker 1: The research in our sources supports that. There’s a five-year durability study published by Gilligan and colleagues in 2024 that highlights the realities of this biological rebuild. It takes months to physically restore a muscle that has been dormant and atrophying for years.
Speaker 2: Because you are waking up an atrophied system. Muscle development — the actual growth of muscle fibers and the re-establishment of neural communication pathways — cannot be rushed by a battery.
Speaker 1: You can’t just jolt it awake.
Speaker 2: No. It requires time and consistent electrical signaling to help the tissue adapt and recover. And that biological reality explains the long-term data. In typical pain management treatments, the effects frequently plateau. The body builds a tolerance. Or the underlying degenerative changes progress and the initial relief fades.
Speaker 1: You end up chasing the pain.
Speaker 2: But the Gilligan data reveals that the proportion of patients achieving major pain reduction actually grew over time. It was around 52% of patients seeing significant relief at year one. That number climbed to around 62% at year three.
Speaker 1: Because the benefit continued to develop.
Speaker 2: Because the muscle was continuing to stabilize the spine, reducing the mechanical strain on the joints. But a thoughtful patient will immediately look for the exit strategy. If a patient waits the six months, dedicates the time to the twice-daily sessions, and the clinical data doesn’t manifest for their specific body — if it yields nothing — what then?
Speaker 1: If a spinal fusion fails, the patient is left with permanently altered bone architecture. You cannot unfuse a spine, which is frightening. But the reversibility of this procedure is a meaningful counterweight to that demanding timeline.
Speaker 2: How reversible is it?
Speaker 1: Fully reversible. Unlike a fusion, no permanent anatomical changes are made to the bone structure. If you reach the six-month mark, the clinical team has tried reprogramming the device, and you still aren’t getting relief, the entire system can be removed in an outpatient procedure.
Speaker 2: No lasting damage?
Speaker 1: No. It does not permanently alter the structural architecture of your spine. For someone afraid of making a decision they cannot undo after a decade of medical disappointment, that reversibility is a real safety net.
Speaker 2: That brings up a logical question, though, that we should address.
Speaker 1: What is it?
Speaker 2: If the entire goal of this surgically implanted device is to rebuild and strengthen the multifidus muscle over a period of months — why does it require surgery? Why couldn’t the patient just strengthen that same muscle themselves at the gym or in a dedicated physical therapy program?
Speaker 1: We have finally hit the deep emotional core of this clinical conversation. Because I know a lot of people are asking that exact question right now.
Speaker 2: Yes, they are. We need to talk about physical therapy guilt.
Speaker 1: It’s a real thing. If you are listening to this and you have battled mechanical back pain for years, I am willing to bet you have spent countless hours staring at a fluorescent clinic ceiling, doing the exercises. You did the dead bugs. You did the pelvic tilts. You held the planks until your arms shook.
Speaker 2: You went to the appointments, you paid the copays, and you pushed through the flare-ups. And when the pain stayed — or got worse — you internalized a very specific, harmful narrative.
Speaker 1: You felt like you failed. Like it was your fault. You felt like your character was flawed. That you simply didn’t try hard enough, or your core just wasn’t strong enough. You carry deep-seated guilt that your decade of pain is somehow a failure of your own willpower.
Speaker 2: The clinical science surrounding this specific dysfunction provides a complete exoneration of that guilt. To understand why physical therapy doesn’t fully resolve these specific cases, we have to unpack a physiological mechanism called arthrogenic muscle inhibition.
Speaker 1: Break that down.
Speaker 2: When you experience a significant injury or chronic ongoing inflammation in a joint — in this case the joints of the lumbar spine — the body deploys a protective reflex. It sends a signal to the spinal cord to automatically inhibit, or shut down, the muscles surrounding that damaged joint.
Speaker 1: Like a defense mechanism.
Speaker 2: Exactly. The body is essentially trying to create a biological cast, preventing further movement to prevent further damage.
Speaker 1: Which is useful for an acute injury.
Speaker 2: It’s a useful evolutionary response for acute injuries. The problem arises in patients with established chronic mechanical back pain. In these patients, that inhibition gets stuck. It doesn’t turn off.
Speaker 1: The spinal cord continually suppresses the multifidus muscle long after the initial injury should have healed.
Speaker 2: The analogy for this completely changed how I view chronic pain.
Speaker 1: What’s the analogy?
Speaker 2: Think of your nervous system like the electrical wiring in a house. You are standing in your living room, flipping the light switch on the wall over and over again. That voluntary action — consciously deciding to flip the switch — is physical therapy. You are using your brain to consciously try to turn the muscle on.
Speaker 1: But the light won’t come on.
Speaker 2: No. Because down in the basement of the house, the main circuit breaker has been tripped. The spinal reflex has locked the system out. You can flip that living room switch until your fingers ache. You can do dead bugs until you collapse. But if the main breaker at the spinal cord level is tripped, the electricity simply cannot reach the bulb.
Speaker 1: The muscle is biologically unable to receive the command to contract.
Speaker 2: Exactly. And the clinical literature supports that analogy. Our sources reference a 2021 study by Songjaroen and colleagues. They found that even after patients underwent thorough, optimized motor control exercise programs — the most targeted physical therapy available — multifidus activation could remain largely unchanged in patients with established dysfunction.
Speaker 1: Wow. The voluntary neural pathway was largely locked out. The brain was sending the signal, but the spinal cord was suppressing it before it could reach the muscle.
Speaker 2: I want the listener to absorb the weight of that data. I want to give you permission to set down the guilt you’ve been carrying for years.
Speaker 1: You did not fail physical therapy. Physical therapy simply couldn’t reach a muscle that was biologically locked behind a tripped circuit breaker.
Speaker 2: Which brings us to the functional premise of the ReActiv8® system. It bypasses the switch in the living room. It is designed to bypass that voluntary pathway entirely. Because the leads stimulate the motor nerve directly at the root, it does not require the brain to send a signal down the spinal cord.
Speaker 1: Right. It elicits the contraction at the nerve itself, bypassing the block, and over months of repeated stimulation, helps reset that tripped breaker.
Speaker 2: That is remarkable. But a thoughtful mind should immediately spot the next problem.
Speaker 1: There’s always another problem.
Speaker 2: Of course. How does a physician actually know? How does a doctor look at a patient and definitively determine if their circuit breaker is tripped, versus a patient who just has a weak back that needs more conditioning?
Speaker 1: That’s a really good question. You cannot guess this from a standard patient interview. And an MRI only shows structure. It doesn’t show muscle function.
Speaker 2: An MRI is a photograph.
Speaker 1: This is where the specific evaluation process at Vertrae® becomes relevant. During a clinical evaluation at Vertrae® in Dayton, Ohio, a physician has to physically test for this specific inhibition. Dr. Kamal Woods uses a precise clinical exam called a prone instability test.
Speaker 2: The mechanics of that exam are interesting. The physician is essentially testing whether the multifidus muscle would be capable of stabilizing the spine if the electrical signal were successfully restored.
Speaker 1: How does it work in the room?
Speaker 2: The patient lies face down on an exam table with their legs hanging off the edge. The physician applies firm downward pressure to the painful segment of the lumbar spine, noting the pain and instability. Then the patient is asked to lift their legs off the floor.
Speaker 1: Which forces the back muscles to engage.
Speaker 2: Exactly. The physician applies pressure again. If the pain diminishes when the legs are lifted, it suggests that the muscle is capable of stabilizing the joint when forced to engage under load — but is otherwise inhibited by that spinal reflex when at rest.
Speaker 1: It provides functional evidence rather than just an image of anatomy.
Speaker 2: Right. It helps confirm that the patient is actually a candidate for motor nerve stimulation. Before anyone discusses a surgical procedure, the clinical team is confirming that the biological deficit exists before offering a biological intervention.
Speaker 1: It is a targeted intervention for a confirmed neuromuscular deficit. It is not a broad-spectrum painkiller.
Speaker 2: So, synthesizing all of this, we have explored some heavy concepts today. And we have honestly acknowledged the friction involved in this deep dive.
Speaker 1: The friction is the defining characteristic of the treatment. We are analyzing a protocol that requires an invasive surgical procedure, followed by two weeks of inactive hardware sitting inside you, followed by months of daily therapy you cannot physically feel — before a patient might even experience meaningful relief.
Speaker 2: It is a slow, physically and mentally demanding process. And it requires real patience from a population of people who have very little patience left to give. It is asking a tired patient to endure a difficult, sometimes frightening timeline.
Speaker 1: But on the other side of that friction is a profound clinical reframe.
Speaker 2: What do you mean?
Speaker 1: It offers a scientific, verifiable reason for why every past treatment may have fallen short. It moves the medical conversation away from masking your symptoms with medications, and toward targeting the root physiological cause of the spinal instability.
Speaker 2: It achieves that structural stabilization while maintaining reversibility. It is a careful biological rebuild of your own existing anatomy — asking your body to recover over time, rather than imposing a permanent structural change to your bones.
Speaker 1: Exploring this any further really comes down to getting that specific clinical evaluation at a place like Vertrae® in Dayton, Ohio. Finding out whether the prone instability test shows that multifidus dysfunction — that locked-out circuit breaker — is your missing puzzle piece.
Speaker 2: It is a matter of gathering functional data on your own body. Having a professional check the breaker box in the basement, so to speak.
Speaker 1: Just checking the breaker.
Speaker 2: As we close out this conversation, think back to the pendulum we talked about at the very beginning. The heavy, stuck feeling. The sense of time swinging back and forth over the same pain, year after year, eroding your ability to look forward.
Speaker 1: We aren’t going to end today with a recommendation, or tell you what medical decision to make next. That is entirely up to you and your doctor.
Speaker 2: But we do want to leave you with one thought to sit with in the quiet moments. A question to consider as you reflect on the history of your own body and the weight you’ve carried. If your decade of pain isn’t a lack of effort, but simply a shut-off signal — what would it mean to finally stop blaming yourself for not healing?
Key Takeaway
ReActiv8® is an outpatient procedure performed under general anesthesia with same-day discharge. Results are gradual — in published follow-up, many patients begin to notice early improvement around 3 months, with progressive gains continuing through 12 to 24 months and outcomes that have generally been durable at 5 years in the studied population. The device is reversible. Insurance coverage is available for qualifying patients, and the Vertrae® team handles verification before anything is scheduled. ReActiv8® is not the same as spinal cord stimulation — it targets a different nerve, a different mechanism, and a different patient population. It addresses the underlying cause of chronic mechanical back pain when physical therapy cannot reach the underlying reflex inhibition. At Vertrae® in Dayton, Dr. Kamal Woods and Jen Leibold, PA-C evaluate every candidate personally before any recommendation is made.
Ready to Get Your Questions Answered for Your Specific Situation? Request an Evaluation at Vertrae®
This post answers the common questions. The questions that actually matter are the ones about your pain, your history, and your life — and those need a real conversation.
At Vertrae® in Dayton, Dr. Kamal Woods evaluates every ReActiv8® candidate personally. The evaluation includes a clinical assessment for multifidus dysfunction and a thorough review of your treatment history — before anything is scheduled. No referral required.
Serving: Dayton • Miamisburg • Beavercreek • Kettering • Centerville • Piqua • Cincinnati • Southwest Ohio
Vertrae® Surgery Center: Spine-exclusive outpatient facility in Miamisburg • near Austin Landing and the I-75/I-675 interchange • same-day discharge
Dr. Kamal Woods, MD, MBA: Dual fellowship-trained neurosurgeon • Cedars-Sinai trained • exclusively minimally invasive & robotic spine surgery
Jen Leibold, PA-C: Physician Assistant | Spine care, patient education, and ReActiv8® clinical management | Vertrae®, Dayton, Ohio
References
Deckers, K., De Smedt, K., Mitchell, B., et al. (2018). New therapy for refractory chronic mechanical low back pain: Restorative neurostimulation to activate the lumbar multifidus — one year results of a prospective multicenter clinical trial. Neuromodulation, 21(1), 48–55. https://doi.org/10.1111/ner.12741
Gilligan, C., Volschenk, W., Russo, M., et al. (2023). Three-year durability of restorative neurostimulation effectiveness in patients with chronic low back pain and multifidus muscle dysfunction. Neuromodulation, 26(1), 98–108. https://doi.org/10.1016/j.neurom.2022.08.457
Gilligan, C., Volschenk, W., Russo, M., et al. (2024). Five-year longitudinal follow-up of restorative neurostimulation shows durability of effectiveness in patients with refractory chronic low back pain associated with multifidus muscle dysfunction. Neuromodulation, 27(5), 930–943. https://doi.org/10.1016/j.neurom.2024.01.006
Mitchell, B., Deckers, K., De Smedt, K., et al. (2021). Durability of the therapeutic effect of restorative neurostimulation for refractory chronic low back pain. Neuromodulation, 24(6), 1024–1032. https://doi.org/10.1111/ner.13477
Schwab, F., Mekhail, N., Patel, K. V., et al. (2025). Restorative neurostimulation therapy compared to optimal medical management: A randomized evaluation (RESTORE) for the treatment of chronic mechanical low back pain due to multifidus dysfunction. Pain and Therapy, 14(1), 401–423. https://doi.org/10.1007/s40122-024-00689-0
Songjaroen, S., Sungnak, P., Piriyaprasarth, P., et al. (2021). Combined neuromuscular electrical stimulation with motor control exercise can improve lumbar multifidus activation in individuals with recurrent low back pain. Scientific Reports, 11(1), 14815. https://doi.org/10.1038/s41598-021-94402-2
Thomson, S., Williams, A., Vajramani, G., et al. (2025). 5-year longitudinal follow-up of patients treated for chronic mechanical low back pain using restorative neurostimulation. Regional Anesthesia and Pain Medicine. https://doi.org/10.1136/rapm-2025-106899
